Population Health Management

Creating a healthier Singapore with digital solutions: Q&A with Glenn Neo

In this insightful interview, Karen Yu, Country Manager for Roche Diagnostics Singapore, sits down with Glenn Neo, Director of Innovation and Capabilities Enablement (ICE) at Synapxe, the national HealthTech agency of Singapore, for a wide-ranging conversation. Together, they explore the vital role of technology in enhancing healthcare services in Singapore, the potential of generative AI, […]

Creating a healthier Singapore with digital solutions: Q&A with Glenn Neo Read More »

How labs can drive real world evidence (RWE) ecosystems

How labs can drive real world evidence (RWE) ecosystems

While some clinical labs and in vitro diagnostic manufacturers are only just beginning to explore opportunities in real world evidence (RWE), others are taking concrete steps to participate in RWE ecosystems. As noted in a recent introductory piece on the topic from June 2022, these efforts include emerging public-private collaborations, such as those driven by

How labs can drive real world evidence (RWE) ecosystems Read More »

Metabolism in precision medicine: small molecules unlock opportunities

Metabolism in precision medicine: small molecules unlock opportunities

Prof Markus R. Wenk of the Precision Medicine Translational Research Programme at NUS outlines how research on individual metabolism—the conversion of food to maintain cellular and organismal life—will offer new opportunities for personalised health and medicine. He discusses the potential capabilities of metabolites, the growing role of biobanks, and the extent to which this information

Metabolism in precision medicine: small molecules unlock opportunities Read More »

Strengthening healthcare systems through the critical role of diagnostics

Strengthening healthcare systems through the critical role of diagnostics

In line with the WHO Essential Diagnostics List (EDL) and Lancet Commission efforts, the Asia Pacific Medical Technology Association and its members recently came together to produce an inaugural paper about the value delivered by diagnostic technologies in the Asia Pacific region. This session covers the latest insights from public-private dialogue on improving the value

Strengthening healthcare systems through the critical role of diagnostics Read More »

Precision medicine and public health: a perfect fit?

Precision medicine and public health: a perfect fit?

From cutting-edge omics to advanced health informatics, the tools of precision medicine are becoming increasingly powerful. While these tools are often used to create targeted treatments that are geared towards small patient groups, some public health practitioners are beginning to explore their potential role in population health management. In this recent webinar hosted by Lab

Precision medicine and public health: a perfect fit? Read More »

Can ‘Clinical Lab 2.0’ help prevent the next pandemic?

Can ‘Clinical Lab 2.0’ help prevent the next pandemic?

  The COVID-19 pandemic shined a bright light on many challenges facing healthcare systems, but it has also demonstrated the importance of laboratory medicine in managing infectious diseases. By strengthening our clinical lab systems, we now have a unique opportunity to not only mitigate the impact of future pandemics, but also manage the growing burden

Can ‘Clinical Lab 2.0’ help prevent the next pandemic? Read More »

‘Real world evidence’ and clinical labs: a brief introduction

‘Real world evidence’ and clinical labs: a brief introduction

As public and private healthcare organisations around the world become increasingly aware of the power of ‘real world evidence’ (RWE) in developing and evaluating medical products, many are launching pilots and seeking policy guidance to explore the opportunity. While biopharma companies have been active in RWE for years, however, in vitro diagnostics manufacturers and clinical

‘Real world evidence’ and clinical labs: a brief introduction Read More »

What is Precision Public Health and why does it matter to clinical labs?

What is ‘Precision Public Health’ and why does it matter to clinical labs?

To effectively manage healthcare systems, public health practitioners have to constantly weigh trade-offs between the needs of society at large and those of specific sub-populations. In the absence of detailed population health data and tools for public health management, these trade-offs can raise difficult operational and ethical questions. The COVID-19 pandemic showed how challenging these

What is Precision Public Health and why does it matter to clinical labs? Read More »

Dr Jeremy Lim on ‘precision public health’ and its potential in Asia (RED 2021)

Dr Jeremy Lim on ‘precision public health’ and its potential in Asia (RED 2021)

As Director of the Leadership Institute for Global Health Transformation at the NUS Saw Swee Hock School of Public Health and Founding President of the Precision Public Health Asia Society, Dr Jeremy Lim is at the forefront of an emerging field that aims to bring precision medicine techniques to population health management. In this presentation

Dr Jeremy Lim on ‘precision public health’ and its potential in Asia (RED 2021) Read More »

A vision for Lab 3.0 in 2050

Tonythumb

In June 2020, author and futurist Tony Estrella published A Vision for APAC in 2050, a whitepaper to stimulate conversation on the future of health in this region. The whitepaper originally appeared on FutureProofing Healthcare, a platform for sharing data and insights to drive evidence-based decision making. This article extends the concepts from this whitepaper

A vision for Lab 3.0 in 2050 Read More »

Scroll to Top